Steven Horwitz, MD - Relapsed/Refractory Peripheral T-Cell Lymphoma: Reviewing Available and Anticipated Strategies in This Rare Malignancy

Visit https://www.peervoice.com/MQC860 to view the entire programme with slides. After completing “Steven Horwitz, MD - Relapsed/Refractory Peripheral T-Cell Lymphoma: Reviewing Available and Anticipated Strategies in This Rare Malignancy”, participants will be able to: Recognize unmet needs surrounding the management of peripheral T-cell lymphoma (PTCL), including the impact of the disease on patient quality of life (QoL); Assess the clinical significance of clinical trial data evaluating the safety and efficacy of novel treatments for the management of relapsed/refractory (R/R) PTCL; and Implement current consensus best practice approaches to the management of R/R PTCL.

Listen